FDA ’s ‘Bad Ad’ Program Encourages HCPs to Report False or Misleading Prescription Drug Promotion

FDA ’s ‘Bad Ad’ Program Encourages HCPs to Report False or Misleading Prescription Drug Promotion
Source: FDA Center for Drug Evaluation and Research - What's New - Category: Drugs & Pharmacology Authors: Source Type: news